Kercher Matthew J, Ramanathan Dinesh, Dahlin Brian C, Yee Alan H, Clouse Jared W, Waldau Ben
Department of Neurological Surgery, UC Davis Medical Center, Sacramento, CA, USA.
Department of Neurology, UC Davis Medical Center, Sacramento, CA, USA.
Neurohospitalist. 2021 Jan;11(1):54-58. doi: 10.1177/1941874420934333. Epub 2020 Jun 25.
Recurrent sequential mechanical thrombectomy for cryptogenic large vessel occlusion (LVO) can lead to excellent clinical outcome. A 68-year-old right-handed male presented with an acute proximal right middle cerebral artery (MCA) ischemic syndrome and underwent successful revascularization by mechanical thrombectomy with normal functional recovery. He was treated with dual antiplatelet therapy for 2 months following discharge, however later discontinued clopidogrel due to side effects. He then developed a recurrent, contralateral MCA occlusion 16 months later and once again received emergent endovascular reperfusion therapy with excellent neurological outcome. He has remained on off-label empiric oral anticoagulation since and has not had recurrent stroke nor evidence of cerebral ischemia. Favorable clinical outcomes can be achieved in patients despite recurrent LVO who underwent emergent mechanical thrombectomy. Optimal antithrombotic secondary stroke prevention strategies following embolic stroke of unknown source remains uncertain as recent evidence does not support rivaroxaban or dabigatran over aspirin. The benefit of apixaban over aspirin for the prevention of recurrent cerebral ischemia is under current investigation.
复发性序贯机械取栓术治疗隐源性大血管闭塞(LVO)可带来优异的临床结局。一名68岁右利手男性,出现急性右侧大脑中动脉(MCA)近端缺血综合征,通过机械取栓术成功实现血管再通,功能恢复正常。出院后他接受了2个月的双重抗血小板治疗,但后来因副作用停用了氯吡格雷。16个月后,他又出现了对侧MCA闭塞,再次接受了紧急血管内再灌注治疗,神经功能结局良好。此后他一直接受非标准的经验性口服抗凝治疗,未再发生卒中,也没有脑缺血的证据。尽管发生复发性LVO,但接受紧急机械取栓术的患者仍可获得良好的临床结局。由于最近的证据并不支持利伐沙班或达比加群优于阿司匹林,因此对于不明来源栓塞性卒中后最佳的抗栓二级预防策略仍不确定。阿哌沙班在预防复发性脑缺血方面优于阿司匹林的益处目前正在研究中。